MedPath

Assessing the Efficacy and Impact of Ambient AI Scribes in Healthcare

Not Applicable
Not yet recruiting
Conditions
Use of Ambient AI Scribes
Patient-Phyisican Interaction
Physician Workload
Physician Burnout
Registration Number
NCT07113938
Lead Sponsor
University of Saskatchewan
Brief Summary

The goal of this clinical trial is to assess the impacts of ambient AI scribes on the workload and burnout in physicians who see patients in a clinic setting at least twice in a week, as well as the impacts on patient-physician interaction.

The main questions it aims to answer are:

* What is the impact of ambient AI scribe use on physician workload and burnout?

* What is the impact of ambient AI scribe use on quality of patient-physician interaction?

Researchers will compare the group of physicians using the ambient AI scribes to the group not using ambient AI scribes to see if there are any significant differences.

Participants randomly assigned to Group A will make use of the AI scribe and participants randomly assigned to Group B will not use any AI scribe for the 10 working day duration of the study. They will be asked to complete a survey assessing workload and burnout immediately prior to the commencement of the study and at the end of each week of the study or 5 full working days for part time physicians. They will also invite their patients to complete a survey assessing their experience after each clinical interaction.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Physicians from family medicine or any specialty
  • Physicians who regularly see patients in a clinic setting at least 2 days per week
Exclusion Criteria
  • Physicians who are planning to leave their practice during the study period

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Physician Workload as Measured Using the NASA Task Load IndexFrom enrolment to the end of the study at 10 working days.

The NASA-TLX is separated into six 100-point scales with 5-point steps that assess mental demand, physical demand, temporal demand, performance, effort, and frustration. A higher score indicates that they feel a greater degree of each of the domains.

Physician Burnout as Measured Using the MBI - HSS (MP)From enrolment to the end of the study at 10 working days.

The MBI-HSS (MP) is created specifically for medical personnel and assesses emotional exhaustion (9 items), depersonalization (5 items), and personal accomplishment (8 items).

Quality of Patient-Physician Interaction As Measured Using the CARE Patient Feedback Measure Domain of "Really Listening"Throughout study completion at 10 working days.

The CARE measure consists of a series of 10 questions asked of patients with our focus on the domain of whether the physician was "really listening (paying close attention to what you were saying; not looking at the notes or computer as you were talking)" scored on a 5 point Likert scale.

Secondary Outcome Measures
NameTimeMethod
Documentation Quality as Measured by the PDQI-9From enrollment to the completion of the study at 10 working days.

Documentation is scored by two blinded reviewers on a scale from 1-5 (with 5 indicating a higher quality) across 9 domains: up-to-date, accurate, thorough, useful, organized, comprehensible, succinct, synthesized, and internally consistent.

Time Spent Within the EMR for Each Clinical NoteFrom enrollment to the completion of the study at 10 working days.

The amount of time spent within the EMR for each clinical note and the amount of time spent editing the note on the ambient AI platform will be tracked using EMR logs and time-tracking tools.

Time Spent in the EMR After HoursFrom enrollment to the completion of the study at 10 working days.

The amount of time spent using the EMR after regular working hours will be measured using EMR logs and time-tracking tools.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.